Site Search

... to support legislation improving Pennsylvanians’ access to biomarker testing. Biomarker testing has become a game-changing part of patient care given its role in opening the door to targeted treatments that can lead to improved survivorship and quality of life. Senate Bill 954 and House Bill 1754 represent a bipartisan proposal to ensure comprehensive biomarker testing is covered by all state-regulated health plans, including Medicaid, when medically appropriate. “I, like too many, have a family history of cancer. My father was diagnosed at a ... fighting cancer if I were to be diagnosed. Because I was screened, tested and received my baseline PSAs in my thirties, I can stay on top of my health,” said Senator Devlin Robinson, co-prime sponsor of Senate Bill 954 . “If someday I do get the dreadful news of cancer, I will have ...

... This success would not have been possible without invaluable patient, provider, academic and legislative partnerships. Over 50 public health and medical organizations supported this effort. We look forward to cancer patients across Georgia benefiting from improved access to care and better quality of life.” For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing and ACS ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as ...

... received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect and treat cancer, but these staggering incidence and mortality rates suggest that many New Yorkers aren’t ... increasingly important for the treatment of other diseases, including arthritis, other autoimmune conditions and rare diseases. Currently, many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker testing for all patients who could benefit, ... tested for certain guideline-indicated biomarkers. With biomarker testing increasingly becoming a standard of care in oncology, it’s time that health insurance plans keep up with innovations in testing and treatment. Improving access to biomarker is a simple way for legislators in Albany ...

... Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due in part to lack of coverage by private health insurance and Medicaid for needed testing. Senate Bill 2201 aims to enable more Rhode Islanders to benefit from biomarker testing, a ... Cancer Action Network (ACS CAN) in Rhode Island: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past many months, we have heard countless stories of the difficulties a patient ... and the Rhode Island Senate for approving this legislation. We urge the House to follow suit and also take this critical step towards reducing health inequities and improving cancer outcomes." For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...